Inspire Investing, LLC Aerie Pharmaceuticals Inc Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$11.32 - $16.63 $165,860 - $243,662	-14,652 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$15.16 - $18.97 $6,731 - $8,422	444 Added 3.13%	14,652 $235,000
Q1 2021 Apr 30, 2021	SELL	$13.12 - $20.9 $16,137 - $25,707	-1,230 Reduced 7.97%	14,208 $254,000
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $22,599 - $35,906	2,478 Added 19.12%	15,438 $209,000
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $135,561 - $187,401	12,960 New	12,960 $153,000

Q1 2018 Apr 13, 2018	SELL	$51.15 - $61.0 $49,359 - $58,865	-965 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$50.85 - $65.1 $49,070 - $62,821	965	965 $58,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.